NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Anika Therapeutics, Inc. ("Anika Therapeutics, Inc.") (NASDAQ:ANIK) concerning possible violations of federal securities laws. Anika issued a press release on July 30, 2025, "announc[ing] topline results from its U.S. pivotal clinical trial […]
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc.") (NYSE:INSP) concerning possible violations of federal securities laws. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results,
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160604&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exelixis, Inc. ("Exelixis, Inc.") (NASDAQ:EXEL) concerning possible violations of federal securities laws. Exelixis issued a press release on July 28, 2025, "report[ing] financial results for the second quarter of 2025" and "provid[ing]
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=160609&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=160608&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Tesla, Inc. (NASDAQ:TSLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tesla-inc-lawsuit-submission-form-2?prid=160607&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
For patients considering plastic surgery with underlying medical conditions, Dr. Thomas A. Pane, MD, offers reassuring guidance in a newly released episode of Ask Dr. Pane, available now on YouTube. In this informative video, Dr. Pane answers a common-and critical-question: “Can I still have plastic surgery if I have a health issue like diabetes, heart
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=160611&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call